Publications by authors named "Zahra Bahrami-Nejad"

The efficacy of current antimitotic cancer drugs is limited by toxicity in highly proliferative healthy tissues. A cancer-specific dependency on the microtubule motor protein KIF18A therefore makes it an attractive therapeutic target. Not all cancers require KIF18A, however, and the determinants underlying this distinction remain unclear.

View Article and Find Full Text PDF

How progenitor cells can attain a distinct differentiated cell identity is a challenging problem given the fluctuating signaling environment in which cells exist and that critical transcription factors are often not unique to a differentiation process. Here, we test the hypothesis that a unique differentiated cell identity can result from a core component of the differentiated state doubling up as a signaling protein that also drives differentiation. Using live single-cell imaging in the adipocyte differentiation system, we show that progenitor fat cells (preadipocytes) can only commit to terminally differentiate after up-regulating FABP4, a lipid buffer that is highly enriched in mature adipocytes.

View Article and Find Full Text PDF

Most mammalian cells have an intrinsic circadian clock that coordinates metabolic activity with the daily rest and wake cycle. The circadian clock is known to regulate cell differentiation, but how continuous daily oscillations of the internal clock can control a much longer, multiday differentiation process is not known. Here, we simultaneously monitor circadian clock and adipocyte-differentiation progression live in single cells.

View Article and Find Full Text PDF

Terminal differentiation is essential for the development and maintenance of tissues in all multi-cellular organisms and is associated with permanent exit from the cell cycle. Failure to permanently exit the cell cycle can result in cancer and disease. However, the molecular mechanisms and timing that coordinate differentiation commitment and cell cycle exit are not yet understood.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates how adeno-associated virus (AAV) enters cells and reaches the nucleus, which is crucial for its use in gene therapy.
  • Researchers conducted genome-wide screens in U-2 OS cells with AAV2 to identify genes that affect AAV transduction efficiency.
  • They identified specific genes that either enhance or inhibit AAV transduction, with one gene, GPR108, playing a key role in the viral trafficking process and showing selectivity for certain AAV serotypes.
View Article and Find Full Text PDF

Glucocorticoid and other adipogenic hormones are secreted in mammals in circadian oscillations. Loss of this circadian oscillation pattern correlates with obesity in humans, raising the intriguing question of how hormone secretion dynamics affect adipocyte differentiation. Using live, single-cell imaging of the key adipogenic transcription factors CEBPB and PPARG, endogenously tagged with fluorescent proteins, we show that pulsatile circadian hormone stimuli are rejected by the adipocyte differentiation control system.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the canonical WNT signaling pathway by conducting genetic analysis in haploid human cells to identify new regulatory mechanisms involving key transcription factors and protein interactions.
  • Findings highlighted several important features, including the role of the transcription factor AP-4, the involvement of AXIN2 in β-catenin activity, and various mechanisms that manage WNT signaling, which can inform future research on other signaling systems.
View Article and Find Full Text PDF

Anthracyclines are among the most effective yet most toxic drugs used in the oncology clinic. The nucleosome-remodeling SWI/SNF complex, a potent tumor suppressor, is thought to promote sensitivity to anthracyclines by recruiting topoisomerase IIa (TOP2A) to DNA and increasing double-strand breaks. In this study, we discovered a novel mechanism through which SWI/SNF influences resistance to the widely used anthracycline doxorubicin based on the use of a forward genetic screen in haploid human cells, followed by a rigorous single and double-mutant epistasis analysis using CRISPR/Cas9-mediated engineering.

View Article and Find Full Text PDF